212 related articles for article (PubMed ID: 34445153)
1. The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms.
Danek PJ; Kuban W; Daniel WA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445153
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
3. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
4. Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy.
Danek PJ; Wójcikowski J; Daniel WA
Toxicol Appl Pharmacol; 2020 Nov; 406():115239. PubMed ID: 32941854
[TBL] [Abstract][Full Text] [Related]
5. The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression.
Sadakierska-Chudy A; Haduch A; Rysz M; Gołembiowska K; Daniel WA
Biochem Pharmacol; 2013 Sep; 86(6):800-7. PubMed ID: 23924605
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms.
Danek PJ; Bromek E; Daniel WA
Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209648
[TBL] [Abstract][Full Text] [Related]
7. The Novel Atypical Antipsychotic Lurasidone Affects Cytochrome P450 Expression in the Liver and Peripheral Blood Lymphocytes.
Danek PJ; Daniel WA
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069119
[TBL] [Abstract][Full Text] [Related]
8. The effects of agomelatine and imipramine on liver cytochrome P450 during chronic mild stress (CMS) in the rat.
Haduch A; Bromek E; Rysz M; Pukło R; Papp M; Gruca P; Łasoń M; Niemczyk M; Daniel WA
Pharmacol Rep; 2020 Oct; 72(5):1271-1287. PubMed ID: 32748256
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of the Regulation of Liver Cytochrome P450 by Brain NMDA Receptors and via the Neuroendocrine Pathway-A Significance for New Psychotropic Therapies.
Pukło R; Bromek E; Haduch A; Basińska-Ziobroń A; Kuban W; Daniel WA
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069162
[TBL] [Abstract][Full Text] [Related]
10. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone.
Mutlib AE; Klein JT
J Pharmacol Exp Ther; 1998 Sep; 286(3):1285-93. PubMed ID: 9732390
[TBL] [Abstract][Full Text] [Related]
11. Rat cytochrome p450 1A and 3A enzymes involved in bioactivation of tegafur to 5-fluorouracil and autoinduced by tegafur in liver microsomes.
Yamazaki H; Komatsu T; Takemoto K; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2001 Jun; 29(6):794-7. PubMed ID: 11353746
[TBL] [Abstract][Full Text] [Related]
12. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
13. Activation of brain serotonergic system by repeated intracerebral administration of 5-hydroxytryptophan (5-HTP) decreases the expression and activity of liver cytochrome P450.
Rysz M; Bromek E; Daniel WA
Biochem Pharmacol; 2016 Jan; 99():113-22. PubMed ID: 26581122
[TBL] [Abstract][Full Text] [Related]
14. The effect of brain serotonin deficit (TPH2-KO) on the expression and activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats.
Haduch A; Bromek E; Kuban W; Basińska-Ziobroń A; Danek PJ; Alenina N; Bader M; Daniel WA
Pharmacol Rep; 2023 Dec; 75(6):1522-1532. PubMed ID: 37848703
[TBL] [Abstract][Full Text] [Related]
15. Effect of Endocannabinoid Oleamide on Rat and Human Liver Cytochrome P450 Enzymes in In Vitro and In Vivo Models.
Dovrtelova G; Zendulka O; Noskova K; Jurica J; Pes O; Dusek J; Carazo A; Zapletalova I; Hlavacova N; Pavek P
Drug Metab Dispos; 2018 Jun; 46(6):913-923. PubMed ID: 29650790
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Chronic Treatment with Lurasidone on Rat Liver Cytochrome P450 Expression and Activity in the Chronic Mild Stress Model of Depression.
Kot M; Haduch A; Papp M; Daniel WA
Drug Metab Dispos; 2017 Dec; 45(12):1336-1344. PubMed ID: 28935656
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of neuroleptic agents on hepatic cytochrome P-450 isozymes in the male rat.
Rane A; Liu Z; Levol R; Bjelfman C; Thyr C; Ericson H; Hansson T; Henderson C; Wolf CR
Biochim Biophys Acta; 1996 Aug; 1291(1):60-6. PubMed ID: 8781526
[TBL] [Abstract][Full Text] [Related]
18. Serotonin Receptors of 5-HT
Bromek E; Rysz M; Haduch A; Daniel WA
Drug Metab Dispos; 2019 Feb; 47(2):80-85. PubMed ID: 30518657
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
Ramakrishna R; Bhateria M; Singh R; Bhatta RS
J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
[TBL] [Abstract][Full Text] [Related]
20. The role of the dorsal noradrenergic pathway of the brain (locus coeruleus) in the regulation of liver cytochrome P450 activity.
Kot M; Sadakierska-Chudy A; Haduch A; Rysz M; Bromek E; Gołembiowska K; Daniel WA
Eur J Pharmacol; 2015 Mar; 751():34-41. PubMed ID: 25637782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
